Trial Outcomes & Findings for Reducing Emergency Diabetes Care for Older African Americans (NCT NCT03466866)

NCT ID: NCT03466866

Last Updated: 2024-05-14

Results Overview

The primary efficacy analysis will consider the number of incident diabetes-related ED visits and/or hospitalizations (i.e., an "event") over 12 months after the index ED visit. Each ED visit or hospitalization is counted as a single event (although an ED visit that leads to a hospitalization is counted once). ED visits and hospitalization will be ascertained through chart reviews and subject self-report.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

156 participants

Primary outcome timeframe

12 months

Results posted on

2024-05-14

Participant Flow

Recruitment period: 1/10/2019 to 10/13/2021

Participant milestones

Participant milestones
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
In-home diabetes education with no goal stetting or telehealth visits
Overall Study
STARTED
78
78
Overall Study
COMPLETED
62
62
Overall Study
NOT COMPLETED
16
16

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Reducing Emergency Diabetes Care for Older African Americans

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=78 Participants
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=78 Participants
In-home diabetes education with no goal setting or telehealth visits EUC (Enhanced Usual Care): In-home diabetes education with no goal setting or telehealth visits
Total
n=156 Participants
Total of all reporting groups
Age, Continuous
56.4 years
STANDARD_DEVIATION 9.5 • n=5 Participants
57.2 years
STANDARD_DEVIATION 9.5 • n=7 Participants
56.8 years
STANDARD_DEVIATION 9.5 • n=5 Participants
Sex: Female, Male
Female
48 Participants
n=5 Participants
50 Participants
n=7 Participants
98 Participants
n=5 Participants
Sex: Female, Male
Male
30 Participants
n=5 Participants
28 Participants
n=7 Participants
58 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
77 Participants
n=5 Participants
76 Participants
n=7 Participants
153 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
78 Participants
n=5 Participants
78 Participants
n=7 Participants
156 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
78 participants
n=5 Participants
78 participants
n=7 Participants
156 participants
n=5 Participants
Stratification variable: Baseline HbA1c < 9.0% vs. > or equal to 9.0%
Baseline HbA1c < 9.0%
40 Participants
n=5 Participants
42 Participants
n=7 Participants
82 Participants
n=5 Participants
Stratification variable: Baseline HbA1c < 9.0% vs. > or equal to 9.0%
Baseline HbA1c > or equal to 9.0%
38 Participants
n=5 Participants
36 Participants
n=7 Participants
74 Participants
n=5 Participants
Stratification variable: Primary care physician at Jefferson
Jefferson primary care physician
40 Participants
n=5 Participants
40 Participants
n=7 Participants
80 Participants
n=5 Participants
Stratification variable: Primary care physician at Jefferson
Non-Jefferson primary care physician
38 Participants
n=5 Participants
38 Participants
n=7 Participants
76 Participants
n=5 Participants
Stratification variable: Discharge status
Discharged home from index visit
38 Participants
n=5 Participants
39 Participants
n=7 Participants
77 Participants
n=5 Participants
Stratification variable: Discharge status
Admitted from index visit
40 Participants
n=5 Participants
39 Participants
n=7 Participants
79 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 months

Population: All randomized participants

The primary efficacy analysis will consider the number of incident diabetes-related ED visits and/or hospitalizations (i.e., an "event") over 12 months after the index ED visit. Each ED visit or hospitalization is counted as a single event (although an ED visit that leads to a hospitalization is counted once). ED visits and hospitalization will be ascertained through chart reviews and subject self-report.

Outcome measures

Outcome measures
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=78 Participants
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=78 Participants
In-home diabetes education with no goal setting or telehealth visits EUC (Enhanced Usual Care): In-home diabetes education with no goal setting or telehealth visits
Number of Incident Diabetes-related ED Visits and/or Hospitalizations
.88 Incidence rate ratio
Interval 0.62 to 1.27
1.29 Incidence rate ratio
Interval 0.93 to 1.79

SECONDARY outcome

Timeframe: 12 months

Population: Participants who provided self-reported data at 6 and 12 months

Patient Satisfaction Questionnaire scores: Mean change from baseline to 12 months. There are seven subscales, and subscale scores range from 1 to 5 with higher scores indicating greater satisfaction.

Outcome measures

Outcome measures
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=54 Participants
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=58 Participants
In-home diabetes education with no goal setting or telehealth visits EUC (Enhanced Usual Care): In-home diabetes education with no goal setting or telehealth visits
Perceived Access to Health Care
General Satisfaction
.22 units on a scale
Interval -0.02 to 0.46
.11 units on a scale
Interval -0.13 to 0.34
Perceived Access to Health Care
Financial Aspects
.13 units on a scale
Interval -0.12 to 0.39
.29 units on a scale
Interval 0.04 to 0.55
Perceived Access to Health Care
Communication
.2 units on a scale
Interval -0.01 to 0.42
.17 units on a scale
Interval -0.04 to 0.38
Perceived Access to Health Care
Accessibility and Convenience
.28 units on a scale
Interval 0.07 to 0.49
.21 units on a scale
Interval 0.0 to 0.41
Perceived Access to Health Care
Interpersonal Manner
.18 units on a scale
Interval -0.01 to 0.37
.09 units on a scale
Interval -0.09 to 0.28
Perceived Access to Health Care
Technical Quality
.27 units on a scale
Interval 0.07 to 0.46
.17 units on a scale
Interval -0.02 to 0.37
Perceived Access to Health Care
Time Spent with Doctor
.03 units on a scale
Interval -0.19 to 0.26
.19 units on a scale
Interval -0.03 to 0.41

SECONDARY outcome

Timeframe: 12 months

Population: All randomized participants

Number of received Diabetes Quality Metrics (e.g., hemoglobin A1c testing, urine screening) by 12 months. The metrics are at least 2 HbA1c tests, 1 lipid test, 1 blood pressure check, 1 diabetes foot exam, and 1 dilated fundus examination. Scores range from 0 to 6, with 6 indicating better access to care.

Outcome measures

Outcome measures
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=78 Participants
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=78 Participants
In-home diabetes education with no goal setting or telehealth visits EUC (Enhanced Usual Care): In-home diabetes education with no goal setting or telehealth visits
Actual Access to Care
3.69 Number of quality metrics met
Interval 3.39 to 4.0
3.42 Number of quality metrics met
Interval 3.12 to 3.73

SECONDARY outcome

Timeframe: 12 months

Population: Participants who provided self-reported data at 6 and 12 months

Frequency of engaging in diabetes self-care behaviors; Scores range from 0 to 100 with higher scores indicating more frequent engagement in diabetes self-management behaviors.

Outcome measures

Outcome measures
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=57 Participants
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=60 Participants
In-home diabetes education with no goal setting or telehealth visits EUC (Enhanced Usual Care): In-home diabetes education with no goal setting or telehealth visits
Change From Baseline to 12 Months on Diabetes Self-Care Inventory Scores
8.02 units on a scale
Interval 4.31 to 11.73
3.57 units on a scale
Interval -0.09 to 7.23

Adverse Events

PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)

Serious events: 36 serious events
Other events: 0 other events
Deaths: 0 deaths

EUC (Enhanced Usual Care)

Serious events: 39 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
PREVENT (Preventing and Reducing Emergency Visits in Diabetes Through Education and Telehealth)
n=78 participants at risk
Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care. PREVENT: Community Health Workers (CHWs), who are race-concordant with participants, will: 1) deliver in-home DM education to increase participants' knowledge and skills; 2) use DM-specific Behavioral Activation to improve DM self-care; and 3) facilitate telehealth visits with the participant's primary care physician (PCP) and a DM nurse educator to increase access to care.
EUC (Enhanced Usual Care)
n=78 participants at risk
In-home diabetes education with no goal stetting or telehealth visits
Gastrointestinal disorders
Gastrointestinal
6.4%
5/78 • Number of events 6 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
12.8%
10/78 • Number of events 15 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Cardiac disorders
Cardiac
11.5%
9/78 • Number of events 11 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
20.5%
16/78 • Number of events 22 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Endocrine disorders
Diabetes-related
6.4%
5/78 • Number of events 5 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
7.7%
6/78 • Number of events 6 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Metabolism and nutrition disorders
metabolic-not diabetes related
1.3%
1/78 • Number of events 2 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Infections and infestations
Infection
12.8%
10/78 • Number of events 11 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
11.5%
9/78 • Number of events 14 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Nervous system disorders
Stroke
2.6%
2/78 • Number of events 3 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
2.6%
2/78 • Number of events 2 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Respiratory, thoracic and mediastinal disorders
COPD
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
2.6%
2/78 • Number of events 2 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Musculoskeletal and connective tissue disorders
musculoskeletal
11.5%
9/78 • Number of events 13 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
6.4%
5/78 • Number of events 5 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Blood and lymphatic system disorders
Blood disorders
2.6%
2/78 • Number of events 7 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
3.8%
3/78 • Number of events 3 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Nervous system disorders
Neurological (excluding stroke)
7.7%
6/78 • Number of events 6 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
7.7%
6/78 • Number of events 7 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Psychiatric disorders
psychiatric
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Respiratory, thoracic and mediastinal disorders
Respiratory
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Respiratory, thoracic and mediastinal disorders
shortness of breath
5.1%
4/78 • Number of events 4 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
3.8%
3/78 • Number of events 3 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Renal and urinary disorders
renal
2.6%
2/78 • Number of events 3 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
3.8%
3/78 • Number of events 6 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Respiratory, thoracic and mediastinal disorders
Pulmonary
2.6%
2/78 • Number of events 2 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
7.7%
6/78 • Number of events 7 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
Surgical and medical procedures
Surgical
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.
1.3%
1/78 • Number of events 1 • 12 months
Adverse events were events that resulted in a hospitalization. Adverse Events were reported by organ system class.

Other adverse events

Adverse event data not reported

Additional Information

Barry Rovner,MD

Thomas Jefferson University

Phone: 215-503-1243

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place